The role of CRISPR in the treatment of sickle cell anemia
| dc.contributor.advisor | Szentesiné Szirák, Krisztina | |
| dc.contributor.advisordept | Humángenetikai Tanszék | hu_HU |
| dc.contributor.author | Nwokorie, Ugochukwu Uzoma | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Polgár, Zsuzsanna | |
| dc.contributor.opponent | Jambrovics, Károly | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Orvosi Vegytani Intézet | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Biokémiai és Molekuláris Biológiai Intézet | hu_HU |
| dc.date.accessioned | 2021-09-16T07:45:49Z | |
| dc.date.available | 2021-09-16T07:45:49Z | |
| dc.date.created | 2021-09-03 | |
| dc.description.abstract | Sickle cell anemia (SCA) is an autosomal recessive disease that gives rise to abnormal hemoglobin, thus impairing the oxygen carrying ability of the red blood cells (RBCs).Up till this point, SCA treatment has been mostly pharmaceutical accompanied by lifestyle modifications. However, since the advent of more precise genome editing tools like CRISPR, there are new, more promising possibilities for SCA therapy.CRISPR-Cas9 genome editing is a technique, based on a bacterial defense system, that can be adapted to modify genes of living organisms. With this tool, a programmed complex consisting of Cas9 nuclease coupled with a single-guide RNA (sgRNA) is delivered into a cell using a vector, and this complex then cuts the genome at a specified location, giving certain desired outcomes based on the induced mutation. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 43 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/321752 | |
| dc.language.iso | en | hu_HU |
| dc.subject | CRISPR | hu_HU |
| dc.subject | sickle cell anemia | hu_HU |
| dc.subject | Mendelian disease | hu_HU |
| dc.subject | gene editing | hu_HU |
| dc.subject | CRISPR-Cas9 | hu_HU |
| dc.subject | genome editing | hu_HU |
| dc.subject.dspace | DEENK Témalista::Biológiai tudományok::Humángenetika | hu_HU |
| dc.title | The role of CRISPR in the treatment of sickle cell anemia | hu_HU |
| dc.title.translated | A CRISPR szerepe a sarlósejtes vérszegénység kezelésében | hu_HU |